Stephen Bentfield

Partner

Overview

Stephen Bentfield is a partner and a member of the firm’s Health Care Group. Stephen counsels health care organizations on a wide range of health care regulatory and transactional matters. His regulatory experience includes helping clients with issues such as fraud and abuse enforcement risk analysis and mitigation, organizational compliance programs and policies, managed care, value-based care, reimbursement, licensure, and state regulatory issues. On the transactional side, Stephen has extensive experience drafting contracts, advising on deal structuring and negotiation, including the creation of joint ventures and other new corporate structures, as well as mergers and acquisitions.

Before joining Crowell, Stephen served as vice president and group general counsel of DaVita Integrated Kidney Care, the value-based care subsidiary of DaVita Inc. In that role, he led the legal team responsible for structuring, advising, and operating the company’s portfolio of renal-specific accountable care organizations (ACOs), risk-based management services agreements with Chronic Condition Special Needs Plans, commercial risk contracts, and other value-based and integrated care arrangements. His work for DaVita included designing, structuring, and drafting the company’s arrangements with over 50 Kidney Contracting Entities, ESCO joint ventures, and Value-based Enterprises (VBEs), including all accompanying supporting agreements such as provider participation agreements, MSO agreements, and ancillary provider agreements.

Career & Education

    • St. Lawrence University, B.A., 1995
    • Suffolk University Law School, J.D., 2003
    • St. Lawrence University, B.A., 1995
    • Suffolk University Law School, J.D., 2003
    • District of Columbia
    • Massachusetts
    • Colorado
    • District of Columbia
    • Massachusetts
    • Colorado

Stephen's Insights

Client Alert | 7 min read | 10.27.26

New Developments in DOJ Whistleblower Policies and HHS Disclosures: Key Takeaways for General Counsel, Chief Compliance Officers, and Boards

On October 20, 2026, the U.S. Department of Justice’s (DOJ) National Fraud Enforcement Division announced a new whistleblower rewards initiative, the Fraud Whistleblower Incentive Program (WHIP). Assistant Attorney General Colin M. McDonald issued a directive earlier this month directing Division leadership to design and implement policies and programs that incentivize whistleblowers to bring forward credible information pertaining to fraud. The new WHIP incentive pays awards of $10,000 to $30,000 for qualifying tips at or around the time criminal charges are filed or unsealed, rather than years later at case resolution....

Stephen's Insights

Client Alert | 7 min read | 10.27.26

New Developments in DOJ Whistleblower Policies and HHS Disclosures: Key Takeaways for General Counsel, Chief Compliance Officers, and Boards

On October 20, 2026, the U.S. Department of Justice’s (DOJ) National Fraud Enforcement Division announced a new whistleblower rewards initiative, the Fraud Whistleblower Incentive Program (WHIP). Assistant Attorney General Colin M. McDonald issued a directive earlier this month directing Division leadership to design and implement policies and programs that incentivize whistleblowers to bring forward credible information pertaining to fraud. The new WHIP incentive pays awards of $10,000 to $30,000 for qualifying tips at or around the time criminal charges are filed or unsealed, rather than years later at case resolution....